Skip to content

Stratus N-Acetylprocainamide Fluorometric Enzyme I

by American Dade 510(k)

Active United States

510(k) K853547

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK853547 Date16 Sep 1985ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 5 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
LAN
Device Class
Class II
Regulation
21 CFR Part 862.3320
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Stratus N-Acetylprocainamide Fluorometric Enzyme I is an enzyme immunoassay device designed for the quantitative measurement of N-acetylprocainamide (NAPA) in biological samples. NAPA is a metabolite of procainamide, a medication used to treat certain heart rhythm disorders, and its levels are monitored to assess drug metabolism and potential toxicity. This device employs fluorometric technology to detect and quantify NAPA concentrations, enabling clinical assessment in toxicology settings.

This device is intended for use in clinical toxicology laboratories and has been cleared by the FDA under 510(k) authorization (K853547). It is classified as a Class II medical device under product code LAN, requiring special controls. The Stratus system operates as a single-use, reagent-based immunoassay, requiring proper storage and handling as specified in the accompanying documentation. No additional regulatory approvals beyond the FDA 510(k) clearance are stated in the provided data.

Other devices from American Dade

See all devices from American Dade →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Stratus N-Acetylprocainamide Fluorometric Enzyme I used for?

    This device measures N-acetylprocainamide (NAPA) levels in biological samples. NAPA is a metabolite of procainamide, a medication used to treat heart rhythm disorders. Monitoring NAPA helps clinicians assess how the body metabolizes procainamide and detect potential toxicity, ensuring safer drug therapy in toxicology settings.

  • How is the Stratus N-Acetylprocainamide Fluorometric Enzyme I supplied and used?

    The device is supplied as a single-use, reagent-based immunoassay designed for use with the Stratus system. Each assay requires proper handling and storage as outlined in the accompanying documentation. It employs fluorometric technology to detect and quantify NAPA concentrations in clinical laboratory settings.

  • Is the Stratus N-Acetylprocainamide Fluorometric Enzyme I sterile?

    The device is intended for single-use in clinical toxicology laboratories. Sterility is maintained through proper packaging and handling procedures specified in the manufacturer’s instructions to ensure reliable results.

  • What regulatory approval does the Stratus N-Acetylprocainamide Fluorometric Enzyme I hold?

    The device has been cleared by the FDA under 510(k) authorization (K853547) and is classified as a Class II medical device under product code LAN. This clearance confirms its substantial equivalence to a predicate device and compliance with applicable regulatory requirements.

  • Can this device be reused, or is it designed for single-use only?

    The Stratus N-Acetylprocainamide Fluorometric Enzyme I is explicitly designed for single-use. Reuse is not recommended or supported, as it could compromise accuracy, sterility, and regulatory compliance. Each assay must be used once and discarded.